Meiogenix Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.52M
Latest Deal Amount
  • Investors
  • 3

Meiogenix General Information


Developer of breeding technologies designed to unlock the unexplored genetic diversity of organisms. The company's technologies modulate the frequency of homologous recombination in eukaryotic cells to expands the natural biodiversity and develop new products through natural breeding, enabling businesses to address global food and industrial challenges.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Media and Information Services (B2B)
Primary Office
  • 27 Rue du Chemin Vert
  • 75011 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Meiogenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 20-Sep-2016 $1.52M 00.000 00.00 Completed Generating Revenue/Not Profitable
2. Early Stage VC (Series A) 26-Nov-2010 00.000 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Meiogenix’s complete valuation and funding history, request access »

Meiogenix Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of breeding technologies designed to unlock the unexplored genetic diversity of organisms. The company's techn
Paris, France
5 As of 2020
0.00 0000-00-00
000000000 00.000

000000 0

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
00000 00000000000
Saint Louis, MO
000 As of 0000
000000000 00000


consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
00000 00000000000
Durham, NC
00 As of 0000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Meiogenix Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Benson Hill Venture Capital-Backed Saint Louis, MO 000 00000 000000000 00000
00000000 Venture Capital-Backed Durham, NC 00 00000 00000000000 00000
000000 Corporation New Brighton, MN 00 0000 00000000 0000
0000000 0000000000 Corporation Wilmington, DE 00000 00000000
To view Meiogenix’s complete competitors history, request access »

Meiogenix Executive Team (4)

Name Title Board Seat Contact Info
Virginie Alexanian Chief Financial Officer
Alain Nicolas Co-Founder & Chief Scientific Officer
Luc Mathis Ph.D Chief Executive Officer & Board Member
Giacomo Bastianelli Ph.D Co-Founder & Board Member
To view Meiogenix’s complete executive team members history, request access »

Meiogenix Board Members (8)

Name Representing Role Since
Eric Terré Ph.D Self Board Member 000 0000
Giacomo Bastianelli Ph.D Self Co-Founder & Board Member 000 0000
Johan Cardoen Ph.D Self Chairman 000 0000
Luc Mathis Ph.D Self Chief Executive Officer & Board Member 000 0000
Thierry Laugel Ph.D Kurma Partners Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Meiogenix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Meiogenix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Agoranov Accelerator/Incubator 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
To view Meiogenix’s complete investors history, request access »